Benzinga··NaScilex Subsidiaries Sell ACEA Pharma to Phoenix Asia in $1B Deal, Nasdaq Listing Planned
Scilex's ACEA subsidiaries sell ACEA Pharma to Phoenix Asia Holdings for $1 billion in stock, with Nasdaq listing expected by Q2 2026.
SCLXSCLXWPHOEmergerpharmaceutical